Versant Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Versant Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20	Closed	-$787	–	2112
2023 Q2	$787	Buy	+20	New	+$706	﹤0.01%	1684

Versant Capital Management's ISEE Position: Q3 2023 in Review

Versant Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 20 shares — an estimated $787 sold.

Versant Capital Management first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $787 in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Versant Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Versant Capital Management sold 20 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $787.
Versant Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Versant Capital Management's IVERIC bio, Inc. Common Stock position peaked at $787 in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Versant Capital Management's 13F filing for Q3 2023, filed 12 Oct 2023.